FourThought Financial’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$4K Sell
185
-33
-15% -$862 ﹤0.01% 1192
2022
Q2
$6K Hold
218
﹤0.01% 1118
2022
Q1
$7K Hold
218
﹤0.01% 1106
2021
Q4
$8K Hold
218
﹤0.01% 1102
2021
Q3
$6K Sell
218
-29
-12% -$984 ﹤0.01% 1183
2021
Q2
$8K Sell
247
-35
-12% -$1.45K ﹤0.01% 1138
2021
Q1
$12K Sell
282
-20
-7% -$939 ﹤0.01% 1009
2020
Q4
$13K Buy
+302
New +$12.6K ﹤0.01% 963

Other funds holding AVNS

FourThought Financial's AVNS Position: Q3 2022 in Review

FourThought Financial reduced its Avanos Medical (AVNS) stake by 15% in Q3 2022, selling an estimated $862 and leaving 185 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

FourThought Financial first reported a position in AVNS in Q4 2020 and has held it in 8 quarters since. The position peaked at $13K in Q4 2020. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2022.

  • FourThought Financial held 185 shares of Avanos Medical worth $4K as of Q3 2022.
  • FourThought Financial sold 33 Avanos Medical shares in Q3 2022, an estimated $862.
  • Avanos Medical made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1192 holding.
  • FourThought Financial first reported a position in Avanos Medical in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's Avanos Medical position peaked at $13K in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.